PT3303567T - Processo de esterilização de um lisado plaquetário - Google Patents

Processo de esterilização de um lisado plaquetário

Info

Publication number
PT3303567T
PT3303567T PT167312313T PT16731231T PT3303567T PT 3303567 T PT3303567 T PT 3303567T PT 167312313 T PT167312313 T PT 167312313T PT 16731231 T PT16731231 T PT 16731231T PT 3303567 T PT3303567 T PT 3303567T
Authority
PT
Portugal
Prior art keywords
plateletary
lipping
sterilization process
sterilization
plateletary lipping
Prior art date
Application number
PT167312313T
Other languages
English (en)
Original Assignee
Maco Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maco Pharma Sa filed Critical Maco Pharma Sa
Publication of PT3303567T publication Critical patent/PT3303567T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/19Platelets; Megacaryocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0644Platelets; Megakaryocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029Radiation
    • A61L2/0035Gamma radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/081Gamma radiation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • A61L2103/05
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • C12N2500/84Undefined extracts from animals from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2529/00Culture process characterised by the use of electromagnetic stimulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT167312313T 2015-05-29 2016-05-27 Processo de esterilização de um lisado plaquetário PT3303567T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1554883A FR3036707B1 (fr) 2015-05-29 2015-05-29 Procede de sterilisation d'un lysat plaquettaire

Publications (1)

Publication Number Publication Date
PT3303567T true PT3303567T (pt) 2020-12-15

Family

ID=54329639

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167312313T PT3303567T (pt) 2015-05-29 2016-05-27 Processo de esterilização de um lisado plaquetário

Country Status (10)

Country Link
US (3) US10946046B2 (pt)
EP (2) EP3303567B1 (pt)
KR (1) KR102671387B1 (pt)
AU (1) AU2016269730B2 (pt)
CA (1) CA2987074C (pt)
ES (1) ES2836131T3 (pt)
FR (1) FR3036707B1 (pt)
PL (1) PL3303567T3 (pt)
PT (1) PT3303567T (pt)
WO (1) WO2016193591A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2334785B2 (en) 2008-09-16 2019-08-14 Mayo Foundation For Medical Education And Research Compositions containing platelet contents
EP4328299A3 (en) 2014-05-16 2024-05-29 Mayo Foundation for Medical Education and Research Cell culture media compositions for primary cells
SG11201913793SA (en) 2017-06-30 2020-01-30 Kolon Life Science Inc Method for assessing validity of cell therapy product
DE112018006568B4 (de) * 2017-12-20 2022-03-03 Sexton Biotechnologies, Inc. (Gesellschaft nach den Gesetzen des Staates Delaware) Verfahren zur Herstellung krankheitserregerreduzierter Thrombozytenzusammensetzungen
FR3077823B1 (fr) * 2018-02-15 2022-01-14 Maco Pharma Sa Procede de preparation d'un lysat plaquettaire irradie
FR3077824B1 (fr) 2018-02-15 2022-01-14 Maco Pharma Sa Procede de preparation d'un lysat plaquettaire irradie
EP3633028A1 (en) * 2018-10-02 2020-04-08 PL BioScience GmbH Method for producing a virus-free platelet lysate material
US20210292740A1 (en) * 2020-03-17 2021-09-23 Arteriocyte, Inc. Methods for viral inactivation of human platelet lysate
FR3108253B1 (fr) * 2020-03-23 2023-10-27 Univ Toulouse 3 Paul Sabatier Mousse de lysat plaquettaire pour la culture cellulaire, la thérapie cellulaire et la régénération tissulaire et procédé d’obtention
US12458740B2 (en) 2022-03-10 2025-11-04 Terumo Bct, Inc. Modular serviceability sleds and interconnections
US12478551B2 (en) 2022-03-10 2025-11-25 Terumo Bct, Inc. Collection bottle with integrated cap, handle, and shield features
US12379916B2 (en) 2022-03-10 2025-08-05 Terumo Bct, Inc. Communications and operation control of apheresis systems
US12521474B2 (en) 2022-03-10 2026-01-13 Terumo Bct, Inc. Soft cassette with integrated features

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2344519B (en) 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
JP2003527210A (ja) 2000-03-23 2003-09-16 クリアラント・インコーポレイテッド 生体材料を滅菌するための方法
US8236538B2 (en) * 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
EP2334785B2 (en) * 2008-09-16 2019-08-14 Mayo Foundation For Medical Education And Research Compositions containing platelet contents
ES2402144T3 (es) 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
CA2826969C (en) * 2010-11-29 2019-02-19 New York Blood Center, Inc. Method of blood pooling and storage
IL210162A0 (en) * 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
ITRM20110500A1 (it) * 2011-09-23 2013-03-24 Futura Stem Cells Sa Lisato piastrinico, usi di esso e metodo per la sua preparazione
PL2851085T3 (pl) * 2012-05-14 2019-12-31 Teijin Limited Kompozycja białka sterylizowana promieniowaniem
AU2013261307B2 (en) * 2012-05-14 2017-12-21 Km Biologics Co., Ltd. Radiation-sterilization-resistant protein composition
EP2733200A1 (en) 2012-11-15 2014-05-21 Biorigen International SA Cell culture supplements
WO2015031465A1 (en) * 2013-08-27 2015-03-05 Cook General Biotechnology Llc Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same

Also Published As

Publication number Publication date
EP3303567B1 (fr) 2020-09-09
US20230321148A1 (en) 2023-10-12
CA2987074A1 (fr) 2016-12-08
US10946046B2 (en) 2021-03-16
US20180289744A1 (en) 2018-10-11
KR20180017046A (ko) 2018-02-20
US20210196758A1 (en) 2021-07-01
AU2016269730A1 (en) 2018-01-18
PL3303567T3 (pl) 2021-04-06
AU2016269730B2 (en) 2022-07-14
EP3778877A1 (fr) 2021-02-17
FR3036707B1 (fr) 2019-05-17
WO2016193591A1 (fr) 2016-12-08
ES2836131T3 (es) 2021-06-24
US12370218B2 (en) 2025-07-29
US11690875B2 (en) 2023-07-04
FR3036707A1 (fr) 2016-12-02
EP3303567A1 (fr) 2018-04-11
KR102671387B1 (ko) 2024-06-03
CA2987074C (fr) 2024-06-11

Similar Documents

Publication Publication Date Title
PT3303567T (pt) Processo de esterilização de um lisado plaquetário
PL3848163T3 (pl) Zespół pojemników
PT3319952T (pt) Processo de produção de canabidiol e delta-9-tetrahidrocanabinol
EP3302794A4 (en) epoxidation
HUE059158T2 (hu) Eljárás pridopidin elõállítására
HUE050124T2 (hu) Eljárás biopolimerek dezacetilezésére
DK3341479T3 (da) LNA-G-Proces
EP3360010A4 (en) BI PHOTONS WITH VOTABLE SOURCE
HUE057118T2 (hu) Folyamat
BR112017001790A2 (pt) processo para a epoxidação de uma olefina
PT3256546T (pt) Processo de despolimerização
EP3265120C0 (en) PROCEDURE
EP3380628A4 (en) milling
EP3323166A4 (en) AUTOMATED MANUFACTURE OF A BIONANO CATALYST
BR112016019246A2 (pt) processo paraa fabricação de hidroclorofluoro-olefinas
MA46454A (fr) Procédé multi-protéase
EP3469357A4 (en) DIAGNOSTIC PROCEDURE
BR112016027819A2 (pt) Processo de preparação de derivados de tiazole
EP3697821A4 (en) PROCEDURE
EP3558903A4 (en) METHOD
EP3286306A4 (en) Novel process
BR112016019843A2 (pt) processo de biorrefinamento
EP3217965C0 (en) Pharmaceutical processing
EP3716786A4 (en) STERILIZATION PROCESS
IL254336A0 (en) Novel treatment method